Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

Antipsychotics and Blood Vessel Function
Cardiovascular Complications of First-line, Second-generation Antipsychotics
Status: Enrolling
Updated:  12/31/1969
University of Iowa Hospitals and Clinics
460
mi
from 43215
Iowa City, IA
Antipsychotics and Blood Vessel Function
Cardiovascular Complications of First-line, Second-generation Antipsychotics
Status: Enrolling
Updated: 12/31/1969
University of Iowa Hospitals and Clinics
460
mi
from 43215
Iowa City, IA
Click here to add this to my saved trials
Effectiveness of Neuroadaptive Cognitive Training in Adolescents at Risk for Psychosis
Neuroscience-Guided Cognitive Remediation in Adolescents at Risk for Psychosis
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
2109
mi
from 43215
San Francisco, CA
Effectiveness of Neuroadaptive Cognitive Training in Adolescents at Risk for Psychosis
Neuroscience-Guided Cognitive Remediation in Adolescents at Risk for Psychosis
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
2109
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Effects of Oxytocin Nasal Spray on Social Affiliation
Effects of Oxytocin Nasal Spray on Social Affiliation
Status: Enrolling
Updated:  12/31/1969
Maryland Psychiatric Research Center
338
mi
from 43215
Catonsville, MD
Effects of Oxytocin Nasal Spray on Social Affiliation
Effects of Oxytocin Nasal Spray on Social Affiliation
Status: Enrolling
Updated: 12/31/1969
Maryland Psychiatric Research Center
338
mi
from 43215
Catonsville, MD
Click here to add this to my saved trials
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
Status: Enrolling
Updated:  12/31/1969
Hartford Hospital- The Institute of Living
554
mi
from 43215
Hartford, CT
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
Status: Enrolling
Updated: 12/31/1969
Hartford Hospital- The Institute of Living
554
mi
from 43215
Hartford, CT
Click here to add this to my saved trials
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
Status: Enrolling
Updated:  12/31/1969
Center for Cognitive Medicine
274
mi
from 43215
Chicago, IL
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
Status: Enrolling
Updated: 12/31/1969
Center for Cognitive Medicine
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins School of Medicine
345
mi
from 43215
Baltimore, MD
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins School of Medicine
345
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
Status: Enrolling
Updated:  12/31/1969
University of Maryland, Baltimore
343
mi
from 43215
Baltimore, MD
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
Status: Enrolling
Updated: 12/31/1969
University of Maryland, Baltimore
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
Status: Enrolling
Updated:  12/31/1969
Wayne State University School of Medicine
164
mi
from 43215
Detroit, MI
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
Status: Enrolling
Updated: 12/31/1969
Wayne State University School of Medicine
164
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern Medical Center
910
mi
from 43215
Dallas, TX
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern Medical Center
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Effects of Pramlintide on Weight Reduction in Clozapine- and Olanzapine-Induced Weight Gain in Obese People Diagnosed With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern Medical Center
910
mi
from 43215
Dallas, TX
Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Effects of Pramlintide on Weight Reduction in Clozapine- and Olanzapine-Induced Weight Gain in Obese People Diagnosed With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern Medical Center
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain
The Attenuation of Second Generation Antipsychotic Induced Weight Gain in Adolescents and Adults Using Betahistine: A Double-Blind, Placebo-Controlled Trial
Status: Enrolling
Updated:  12/31/1969
Nathan Kline Insitute for Psychiatric Research
481
mi
from 43215
Orangeburg, NY
Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain
The Attenuation of Second Generation Antipsychotic Induced Weight Gain in Adolescents and Adults Using Betahistine: A Double-Blind, Placebo-Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Nathan Kline Insitute for Psychiatric Research
481
mi
from 43215
Orangeburg, NY
Click here to add this to my saved trials
Transcranial Direct Current Brain Stimulation to Treat Patients With Childhood-Onset Schizophrenia
Safety of Transcranial Direct Current Brain Stimulation (TDCS) for Improvement of Psychotic Symptoms and Cognitive Functioning in Childhood Onset Schizophrenia (COS)
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Transcranial Direct Current Brain Stimulation to Treat Patients With Childhood-Onset Schizophrenia
Safety of Transcranial Direct Current Brain Stimulation (TDCS) for Improvement of Psychotic Symptoms and Cognitive Functioning in Childhood Onset Schizophrenia (COS)
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
Cognitive Training to Enhance VA Work Program Outcomes
Cognitive Training to Enhance VA Work Program Outcomes
Status: Enrolling
Updated:  12/31/1969
VA Connecticut Healthcare System
535
mi
from 43215
West Haven, CT
Cognitive Training to Enhance VA Work Program Outcomes
Cognitive Training to Enhance VA Work Program Outcomes
Status: Enrolling
Updated: 12/31/1969
VA Connecticut Healthcare System
535
mi
from 43215
West Haven, CT
Click here to add this to my saved trials
Prospective Studies of the Pathogenesis of Schizophrenia
Prospective Studies of the Pathogenesis of Schizophrenia (Center Title) Early Brain Development in High Risk Children (Project Title) Early Brain Development in One and Two Year Olds (Associated Grant Title)
Status: Enrolling
Updated:  12/31/1969
UNC Department of Psychiatry
344
mi
from 43215
Chapel Hill, NC
Prospective Studies of the Pathogenesis of Schizophrenia
Prospective Studies of the Pathogenesis of Schizophrenia (Center Title) Early Brain Development in High Risk Children (Project Title) Early Brain Development in One and Two Year Olds (Associated Grant Title)
Status: Enrolling
Updated: 12/31/1969
UNC Department of Psychiatry
344
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Improving Representative Payeeship for People With Psychiatric Disabilities and Their Families
Improving Representative Payeeship for People With Psychiatric Disabilities and Their Families
Status: Enrolling
Updated:  12/31/1969
UNC Chapel Hill
344
mi
from 43215
CHapel Hill, NC
Improving Representative Payeeship for People With Psychiatric Disabilities and Their Families
Improving Representative Payeeship for People With Psychiatric Disabilities and Their Families
Status: Enrolling
Updated: 12/31/1969
UNC Chapel Hill
344
mi
from 43215
CHapel Hill, NC
Click here to add this to my saved trials
Prevention of Weight Gain and Dyslipidemia by Green Tea in Patients Initiating Therapy With Olanzapine
Prevention of Weight Gain and Dyslipidemia by Green Tea in Patients Initiating Therapy With Olanzapine
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Prevention of Weight Gain and Dyslipidemia by Green Tea in Patients Initiating Therapy With Olanzapine
Prevention of Weight Gain and Dyslipidemia by Green Tea in Patients Initiating Therapy With Olanzapine
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
Treatment Response in Schizophrenia: Bridging Imaging and Postmortem Studies
Treatment Response in Schizophrenia: Bridging Imaging and Postmortem Studies
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham, Department of Psychiatry, SC 501
493
mi
from 43215
Birmingham, AL
Treatment Response in Schizophrenia: Bridging Imaging and Postmortem Studies
Treatment Response in Schizophrenia: Bridging Imaging and Postmortem Studies
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham, Department of Psychiatry, SC 501
493
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia
Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Univ of Massachusetts Med School
604
mi
from 43215
Worcester, MA
Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia
Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Univ of Massachusetts Med School
604
mi
from 43215
Worcester, MA
Click here to add this to my saved trials
Effects of Delta-9-THC and Iomazenil in Healthy Humans
Gamma-Amino Butyric Acid (GABA) Deficits and Vulnerability to Cannabinoid-Induced Psychosis
Status: Enrolling
Updated:  12/31/1969
VA Connecticut Healthcare System
535
mi
from 43215
West Haven, CT
Effects of Delta-9-THC and Iomazenil in Healthy Humans
Gamma-Amino Butyric Acid (GABA) Deficits and Vulnerability to Cannabinoid-Induced Psychosis
Status: Enrolling
Updated: 12/31/1969
VA Connecticut Healthcare System
535
mi
from 43215
West Haven, CT
Click here to add this to my saved trials
Assessment of Craving in Nicotine-Dependent Patients With Schizophrenia Using Virtual Reality
Assessment of Craving in Nicotine-Dependent Patients With Schizophrenia Using Virtual Reality
Status: Enrolling
Updated:  12/31/1969
University of Maryland at Baltimore/MPRC
337
mi
from 43215
Catonsville, MD
Assessment of Craving in Nicotine-Dependent Patients With Schizophrenia Using Virtual Reality
Assessment of Craving in Nicotine-Dependent Patients With Schizophrenia Using Virtual Reality
Status: Enrolling
Updated: 12/31/1969
University of Maryland at Baltimore/MPRC
337
mi
from 43215
Catonsville, MD
Click here to add this to my saved trials
Dopamine Function and Reward Processing In Schizophrenia
Dopamine Function and Reward Processing In Schizophrenia
Status: Enrolling
Updated:  12/31/1969
University of Maryland, Baltimore
343
mi
from 43215
Baltimore, MD
Dopamine Function and Reward Processing In Schizophrenia
Dopamine Function and Reward Processing In Schizophrenia
Status: Enrolling
Updated: 12/31/1969
University of Maryland, Baltimore
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Dopamine Function and Reward Processing In Schizophrenia
Dopamine Function and Reward Processing In Schizophrenia
Status: Enrolling
Updated:  12/31/1969
National Institute on Drug Abuse, Biomedical Research Center
347
mi
from 43215
Baltimore, MD
Dopamine Function and Reward Processing In Schizophrenia
Dopamine Function and Reward Processing In Schizophrenia
Status: Enrolling
Updated: 12/31/1969
National Institute on Drug Abuse, Biomedical Research Center
347
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Influence of Nicotine on Cognitive Function in Schizophrenic Patients With and Without Comorbid Drug Dependence
Influence of Nicotine on Cognitive Function in Schizophrenic Patients With and Without Comorbid Drug Dependence
Status: Enrolling
Updated:  12/31/1969
Matthews Media Group
317
mi
from 43215
Rockville, MD
Influence of Nicotine on Cognitive Function in Schizophrenic Patients With and Without Comorbid Drug Dependence
Influence of Nicotine on Cognitive Function in Schizophrenic Patients With and Without Comorbid Drug Dependence
Status: Enrolling
Updated: 12/31/1969
Matthews Media Group
317
mi
from 43215
Rockville, MD
Click here to add this to my saved trials
Influence of Nicotine on Cognitive Function in Schizophrenic Patients With and Without Comorbid Drug Dependence
Influence of Nicotine on Cognitive Function in Schizophrenic Patients With and Without Comorbid Drug Dependence
Status: Enrolling
Updated:  12/31/1969
National Institute on Drug Abuse, Biomedical Research Center
347
mi
from 43215
Baltimore, MD
Influence of Nicotine on Cognitive Function in Schizophrenic Patients With and Without Comorbid Drug Dependence
Influence of Nicotine on Cognitive Function in Schizophrenic Patients With and Without Comorbid Drug Dependence
Status: Enrolling
Updated: 12/31/1969
National Institute on Drug Abuse, Biomedical Research Center
347
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
DECIFER: Depression and Citalopram In First Episode Recovery
Citalopram in First Episode Schizophrenia
Status: Enrolling
Updated:  12/31/1969
New York University Langone Medical Center/ Bellevue Hospital
477
mi
from 43215
New York, NY
DECIFER: Depression and Citalopram In First Episode Recovery
Citalopram in First Episode Schizophrenia
Status: Enrolling
Updated: 12/31/1969
New York University Langone Medical Center/ Bellevue Hospital
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1949
mi
from 43215
National City, CA
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1949
mi
from 43215
National City, CA
Click here to add this to my saved trials
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1967
mi
from 43215
Norwalk, CA
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1967
mi
from 43215
Norwalk, CA
Click here to add this to my saved trials
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1964
mi
from 43215
Pasadena, CA
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1964
mi
from 43215
Pasadena, CA
Click here to add this to my saved trials
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
274
mi
from 43215
Chicago, IL
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
789
mi
from 43215
Shreveport, LA
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
789
mi
from 43215
Shreveport, LA
Click here to add this to my saved trials
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
921
mi
from 43215
Desoto, TX
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
921
mi
from 43215
Desoto, TX
Click here to add this to my saved trials
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1998
mi
from 43215
Bellevue, WA
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1998
mi
from 43215
Bellevue, WA
Click here to add this to my saved trials
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1962
mi
from 43215
Anaheim, CA
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1962
mi
from 43215
Anaheim, CA
Click here to add this to my saved trials
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1963
mi
from 43215
Garden Grove, CA
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1963
mi
from 43215
Garden Grove, CA
Click here to add this to my saved trials
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1965
mi
from 43215
Pico Rivera, CA
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1965
mi
from 43215
Pico Rivera, CA
Click here to add this to my saved trials
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1935
mi
from 43215
Riverside, CA
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1935
mi
from 43215
Riverside, CA
Click here to add this to my saved trials
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1951
mi
from 43215
San Diego, CA
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1951
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
970
mi
from 43215
Plantation, FL
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
970
mi
from 43215
Plantation, FL
Click here to add this to my saved trials
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
535
mi
from 43215
Pittsfield, MA
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
535
mi
from 43215
Pittsfield, MA
Click here to add this to my saved trials
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
394
mi
from 43215
Saint Louis, MO
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
394
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
478
mi
from 43215
Brooklyn, NY
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
478
mi
from 43215
Brooklyn, NY
Click here to add this to my saved trials
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
491
mi
from 43215
Cedarhurst, NY
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
491
mi
from 43215
Cedarhurst, NY
Click here to add this to my saved trials
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
64
mi
from 43215
Dayton, OH
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
64
mi
from 43215
Dayton, OH
Click here to add this to my saved trials
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
849
mi
from 43215
Oklahoma City, OK
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
849
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
416
mi
from 43215
Philadelphia, PA
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
527
mi
from 43215
Charleston, SC
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
527
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1069
mi
from 43215
Austin, TX
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1069
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
991
mi
from 43215
Houston, TX
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-288 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-126 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1967
mi
from 43215
Cerritos, CA
Safety and Efficacy Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-126 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1967
mi
from 43215
Cerritos, CA
Click here to add this to my saved trials
Safety and Efficacy Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-126 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1935
mi
from 43215
Escondido, CA
Safety and Efficacy Study for Cognitive Deficits in Adult Subjects With Schizophrenia
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-126 in the Treatment of Cognitive Deficits in Schizophrenia (CDS)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1935
mi
from 43215
Escondido, CA
Click here to add this to my saved trials